Critique of FDA’s latest SSRI Data Analysis
PRESS BRIEFING: Critique of FDA Report: “Clinical review relationship between antidepressant drugs and suicidality in adults, 2006” http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-index.htm
-
-
FDA Rescinds–Advisory Hearing on Suicide Opened to Speakers WhoWere Locked Out
Two Press Briefings are planned to demonstrate the multiple flaws in FDA's methodology and to provide credible science-based information.
-
Another Psych Drug Demonstrated to be USELESS / HARMFUL_Yale /Columbia
"the first-ever randomized, placebo-controlled trial for the alleviation of post-traumatic stress disorder (PTSD)" reports: "we found that it really offered patients no benefits of any symptoms." [1]
-
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.
-
NIH Secrets Government Funded Data Concealment_Lenzer-New Republic
An eye opening article by Jeanne Lenzer, “NIH Secrets,” in The New Republic (below), should make the new Congress sit up and take notice!
-
Flu Vaccine–where is the evidence?
This is an addendum to yesterday's Infomail in which we disseminated disinformation issued by the U.S. Center for Disease Control (CDC). www.ahrp.org/cms/content/view/396/80
-
Conflict of Interest | Corrupt Practices | Gov. Medical Malfeasance | Government Agencies | Pharma Corrupt Influence
Former State Pharmacist (Pennsylvania) Faces Criminal charges
Steven Fiorello, former Chief Pharmacist for the State of Pennsylvania, was arraigned on on Tuesday, November 21, 2006, on Felony and Misdemeanor charges related to his accepting money from drug companies whose drugs he put on the state Formulary.
-
Separating the Facts from the Propaganda_Latest Findings of Depression Study
Today's news report circulated by the media about the negative findings of a much touted, but uncontrolled observational study of depression (STAR*D) promotes the business interests of SSRI antidepressant drug manufacturers.
-
NIMH Chief Child/Adoles Research Blows Wind out TeenScreen Sails_ Los Angeles Times
"Some politicians, public health officials, mental health activists and pharmaceutical companies have worked to establish mental-health screening programs in schools and the community….Researchers and clinicians, meanwhile, say they are far from having developed accurate predictors of a child developing depression. The younger the child, the murkier the crystal ball."
-
Statement by Vera Hassner Sharav, President AHRP: 2/2/04 Press Briefing
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P, New York, NY 10023 Tel. No: 212-595-8974, Fax No: 212-595-9086 ***PRESS BRIEFING 2/2/04*** Statement by Vera Hassner Sharav, President, AHRP The Alliance for Human Research Protection is convening this press conference because we believe a fair and…
-
Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D
Psychopharmacology in Turmoil: David Healy, MD Presentation Columbia + Debate Dr. Joseph Coyne, Ph.D Fri, 9 Dec 2005 Recent reports describing a determined effort to pathologize US infants and toddlers who are being declared to suffer from “severe mental disorders”–the latest, most aggressively marketed diagnosis for children is Bipolar disorder,…
-
Behind the Rampage /Erie Parallels Are Seen to Shootings at Columbine–Psychotropic Drugs – NYT
Behind the Rampage /Erie Parallels Are Seen to Shootings at Columbine–psychotropic drugs – NYT Wed, 23 Mar 2005 There is no doubt that Jeff Weise, the 16 year old boy who went on a shooting rampage, killing 10 people, was a very troubled boy. He had plenty of circumstantial reasons,…